Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. InnoCan Pharma Corporation
  6. Company
    INNO   CA45783P1027

INNOCAN PHARMA CORPORATION

(INNO)
SummaryQuotesChartsNewsCompanyFinancials 
Business Summary
Logo InnoCan Pharma Corporation
Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. The Company is developing an OTC topical treatments product line and new platform to facilitate the targeted controlled administration of cannabinoids via injection.
Sales per Business
20192020Delta
Cannabidiol-integrated Pharmaceuticals--0.01100%-
CAD in Million
Sales per region
20192020Delta
Israel--0.01100%-
CAD in Million
Managers
Name Title Age Since
Iris Or Gabi Bincovich Chief Executive Officer & Director - 2018
Nelson Halpern Chief Financial Officer - -
Nir Avram Chief Technology Officer 67 -
William C. MacDonald Independent Director 64 2018
Eyal Flom Secretary & Director 55 2020
Yoram Nathan Drucker Director & Vice President-Business Development 55 2018
Members of the board
Name Title Age Since
Ron Abraham Mayron Executive Chairman 58 2019
William C. MacDonald Independent Director 64 2018
Iris Or Gabi Bincovich Chief Executive Officer & Director - 2018
Yoram Nathan Drucker Director & Vice President-Business Development 55 2018
Ralph C. L. Bossino Director - 2019
Joshua Aaron Lintern Director 33 2019
Eyal Flom Secretary & Director 55 2020
Peter David Bloch Director 60 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 221,297,497 158,421,150 71.6% 0 0.0% 71.6%
Shareholders
NameEquities%
Solsken Ltd. 44,706,986 20.3%
Yoram Druker 12,201,000 5.53%
Ron Abraham Mayron 5,160,000 2.34%
Iris Or Gabi Bincovich 2,859,750 1.30%
Eyal Flom 1,837,500 0.83%
Daryl S. Fridhandler 750,001 0.34%
Nelson Halpern 500,000 0.23%
Peter David Bloch 0 -
Ralph C. L. Bossino 0 -
Nir Avram 0 -
Company contact information
InnoCan Pharma Corp.
10 Hamenofim Street
Herzliya, Tel Aviv 4672561

Web : http://www.innocanpharma.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of InnoCan Pharma Corporation
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
INNOCAN PHARMA CORPORATION150.75%166
JOHNSON & JOHNSON1.74%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY41.54%215 657
MERCK & CO., INC.-4.24%198 283
ABBVIE INC.0.26%193 205
ASTRAZENECA PLC18.77%187 492
NOVARTIS AG-8.03%186 330
BRISTOL-MYERS SQUIBB COMPANY-8.21%129 683
SANOFI6.53%122 086
AMGEN INC.-11.65%118 022
GLAXOSMITHKLINE PLC3.99%96 396
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-28.73%57 462
BAYER AG-3.20%54 575
JIANGSU HENGRUI MEDICINE CO., LTD.-47.14%49 566
DAIICHI SANKYO COMPANY, LIMITED-19.67%49 400
TAKEDA PHARMACEUTICAL COMPANY LIMITED-14.59%44 517
ASTELLAS PHARMA INC.24.22%32 494